I was excited to dive into a new topic outside of the realm of anxiety and depression. The first article written by Ayaan in 2011 addressed the genetic components of Schizophrenia, looking at Disrupted-In Schizophrenia-1 (DISC1)as a risk factor for schizophrenia and other psychiatric disorders. The gene expression was looked at in different stages pre, post, and both Pre + Post-natally. This article found differences in the timing of this expression as well as gender differences between male and female mice. I immediately appreciated the inclusion of two genders in this study, an approach lacking in most animal models. Many of the results regarding increased aggression were expected considering my previous knowledge of this disorder. However, I was surprised with the results regarding female mice with increase immobility in the tail suspension and forced swim tests. Given the general increased locomotion as a behavioral phenotype stereotypically associated with this disorder I found it interesting that they spent greater time immobile compared to NO mice. In addition I would be curious to learn more about why there were such stark differences here between genders. While there are several differences in the results the authors do not address them in the discussion or speculate the causality. The Ayaan article brings to the forefront the involvement of dopaminergic as well as glutamanergic neurotransmitters and systems in the pathology of schizophrenia. This notion created a good transition into reading the second article by Burrows in 2015. While this article focuses on glutaminergic receptors on a molecular level, the large take away from this study in my opinion is the effect of environmental enrichment (EE) on molecular and behavioral levels of the phenotypic expression of schizophrenia. This article takes a deep dive into the environmental component of this disorder, a topic not deeply understood especially in animal models. They were able to show that positive environmental stimuli were able to ameliorate the behaviors of a schizophrenia model. Behaviors like reduced hyperactivity and improved memory and learning were shown to directly result from an EE paradigm. In addition positive changes also occurred after treatment with clonazapam, which would be expected with anxiety like behaviors. It was exciting to read about potential improvements to treatment methods as well as a greater understanding of the environmental components of these psychological disorders.
April 13 Papers (Buffington et. al, Reber et. al) I found this week’s papers to be quite novel in that they both proposed potential treatments for neurodevelopmental or psychiatric disorders that target bacterial or microbial abnormalities and how these give rise to certain behavioral and physical symptoms associated with the disorders. I thought this was a very unusual yet interesting approach, and as I have not previously studied the gut-brain axis, these papers offered me a fresh perspective on researching psychiatric and neurodevelopmental disorders. They were also unconventional in their focus of the physical symptoms that often accompany mental disorders, as this is not something that I have seen many other papers touch upon very much. Particularly, I was surprised by the Reber et al paper’s focus on the link between psychiatric disorders and inflammation in organs other than the brain, such as the colon, and the Buffington et al paper’s description of a relationship between ...
Comments
Post a Comment